Silicon Laboratories (LA5) AI Stock Analysis

Silicon Laboratories

(XETRA:LA5)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Debt-free balance sheetA debt-free balance sheet and substantial equity base provide financial flexibility, reduce refinancing risk, and help Silicon Labs fund product development or manage cyclical semiconductor demand without heavy leverage.

Negative Factors

Persistent operating lossesNegative operating and net income show that healthy gross margins have not yet translated into sustainable earnings. Continued losses could constrain internal investment capacity and indicate that the recovery remains incomplete.

Silicon Laboratories (LA5) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 7.42B
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -188.3
Beta (1Y): 0.66
Revenue Growth: 13.55%
EPS Growth: 65.84%
Country: Germany
Employees: 1,930
Sector: Technology
Sector Strength: 61
Industry: Semiconductors

Silicon Laboratories Business Overview & Revenue Model

Company Description

Silicon Laboratories Inc., a fabless semiconductor company, provides mixed-signal analog intensive products in the United States, China, Taiwan, and internationally. Its products are used in various electronic products in a range of applications for...

Silicon Laboratories Earnings Call Summary

Earnings Call Date:Nov 03, 2025(Q3-2025)|% Change Since:82.57%|Next Earnings Date:Nov 03, 2026

Earnings Call SentimentPositive

Silicon Labs reported strong revenue growth and improved gross margins, driven by strategic execution and innovation in IoT. However, some challenges remain with customer inventory levels and sustainable gross margins. Overall, the company's outlook remains positive with expectations for continued market share gains.

Positive Updates

Strong Revenue Growth

Silicon Labs expects full-year revenue growth of 34% compared to 2024, with a diverse set of industrial applications driving a 7% sequential increase to $206 million in the September quarter.

Negative Updates

Onetime Benefit in Gross Margin

The December quarter includes an expected onetime benefit to gross margins, which adds approximately 200 basis points, indicating that current gross margins may not be sustainable long-term.

Company Guidance

In the Silicon Labs Third Quarter Fiscal 2025 Conference Call, the company provided robust guidance and an optimistic outlook based on their recent financial performance. For the full year, they anticipate a 34% revenue growth compared to 2024, driven by strong demand in industrial and commercial sectors and a significant uptick in smart meter and medical applications. In Q3, revenue reached $206 million, a 7% sequential increase, and a 24% rise year-over-year. They project Q4 revenue between $200 million and $215 million, with gross margins expected to expand to 62%-64%. This margin increase incorporates a one-time benefit contributing about 200 basis points. Additionally, the company forecasted a non-GAAP operating expense range of $110 million to $112 million and anticipated non-GAAP earnings per share of $0.40 to $0.70. They highlighted strategic innovations like the Studio 6 enablement platform and Simplicity AI SDK, which are expected to accelerate IoT market penetration and drive long-term growth.

Silicon Laboratories Risk Analysis

Silicon Laboratories disclosed 42 risk factors in its most recent earnings report. Silicon Laboratories reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Silicon Laboratories Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

DE:LA5 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SMTC	65Neutral	$11.89B	76.86	25.26%	―	17.84%	464.80%
Sector *	61Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
SWKS	61Neutral	$20.60B	45.14	5.04%	3.24%	0.06%	-22.93%
SYNA	59Neutral	$4.68B	-9.34	-38.70%	―	11.44%	-940.34%
MXL	50Neutral	$6.14B	-192.77	-6.11%	―	56.02%	83.39%

* Technology Sector Average

Performance Comparison

DE:LA5 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:LA5	Silicon Laboratories	199.00	90.00	82.57%
MXL	Maxlinear	67.47	51.85	331.95%
SMTC	Semtech Corp.	127.38	60.13	89.41%
SWKS	Skyworks Solutions	87.58	12.80	17.12%
SYNA	Synaptics	117.86	46.84	65.95%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Silicon Laboratories AI Stock Analysis